Researchers to study benefits, side effects of four widely used therapies in adults with type 2 diabetes

Published on June 18, 2013 at 2:17 AM · No Comments

UT Southwestern Medical Center researchers are seeking 150 adults with type 2 diabetes to take part in the local arm of a major national clinical trial that will compare benefits and side effects of four widely used therapies to lower blood-sugar levels.

Diabetes specialists at UT Southwestern and at 36 other sites across the country are testing the four medications, which will be used in combination with metformin, the most common first-line diabetes medication, to compare the long-range effect on lowering blood-sugar (glucose) levels, complications, and overall quality of life over a five-year span.

"We need to know which combination of medications works best and has fewer side effects so that we can recommend the best choice for our patients," said Dr. Philip Raskin, professor of internal medicine who will lead the UT Southwestern investigation. "Since these drugs are already widely in use, the best way to do that is a head-to-head comparison on a variety of factors."

The National Institutes of Health-funded study, called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study, launched today. Individuals interested in taking part at UT Southwestern can contact 214-DIABETES (214-342-2383) to see if they qualify for this or other diabetes-related trials.

Researchers are recruiting volunteers, age 30 and older, who have been diagnosed with type 2 diabetes within the past five years. Those who qualify may be on metformin, but not on any other diabetes medication. During the study, all trial participants selected will take metformin, along with a second medication randomly assigned. All medications are approved for use with metformin by the U.S. Food and Drug Administration. GRADE participants will have their diabetes medications provided free of charge and managed, including at least four medical visits per year. Other health care will be received through their own providers.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post